
FOXO4-DRI
D-retro-inverso FOXO4 peptide that disrupts FOXO4–p53 binding; a key tool compound in senolytic research.
⚠ For research use only · Not for human use · Not FDA approved

D-retro-inverso FOXO4 peptide that disrupts FOXO4–p53 binding; a key tool compound in senolytic research.
⚠ For research use only · Not for human use · Not FDA approved
A short research-handling guide for FOXO4-DRI. For laboratory and research use only.
D-retro-inverso FOXO4 peptide that disrupts FOXO4–p53 binding; a key tool compound in senolytic research.
FOXO4-DRI is supplied as a lyophilized (freeze-dried) powder. Reconstitute it before research use. Recommended diluent: bacteriostatic water.
Example: 2 ml of diluent in this 10 mg vial gives 5,000 mcg/ml.
Refrigerate 2–8 °C. Keep lyophilized vials frozen and out of light. Once reconstituted, refrigerate (2–8 °C) and use within a few weeks. Always use sterile technique.
For laboratory and research use only. Not for human or veterinary use, food, or drug applications.